XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
  Depression
  Neuropsychiatry
  Personality Disorders
  Bulimia
  Anxiety
  Substance Abuse
  Suicide
  CFS
  Psychoses
   Bipolar Disorder
   Schizophrenia
  Child Psychiatry
  Learning-Disabilities
  Psychology
  Forensic Psychiatry
  Mood Disorders
  Sleep Disorders
  Peri-Natal Psychiatry
  Psychotherapy
  Anorexia Nervosa
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

Schizophrenia Channel
subscribe to Schizophrenia newsletter

Latest Research : Psychiatry : Psychoses : Schizophrenia

   DISCUSS   |   EMAIL   |   PRINT
Schizophrenia can be predicted years before development
Jan 7, 2005, 04:42, Reviewed by: Dr.



 
It is possible to predict with some accuracy which people in a high-risk group who will (and will not) develop schizophrenia, some years before the development of the psychosis. The latest publication from the Edinburgh High-Risk Study, which appears in the January 2005 issue of the British Journal of Psychiatry, has shown that among people at increased genetic risk of schizophrenia, a state of vulnerability will occur in many more individuals than will actually develop the disorder.

Simple behavioural measures of e.g. social withdrawal or odd behaviour, and 'schizotypal' thinking ('sometimes I get a weird feeling that I am not really here') provide the best evidence for distinguishing high-risk individuals who will develop schizophrenia from those who will not.

The purpose of the Edinburgh High-Risk Study, which began in 1994, is to determine what distinguishes high-risk individuals who go on to develop schizophrenia from those who do not, and to compare relevant factors in affected and unaffected high-risk people with matched controls.

A high-risk sample was recruited of 163 young adults aged 16-24 with two relatives with schizophrenia. The control groups were made up of young people who were well, and individuals in the first episode of schizophrenia who did not have a family risk of the disorder.

In this study the high-risk group and 36 controls were examined. Baseline measures were compared between those who did develop schizophrenia, a well control group, a well high-risk group and high-risk participants with partial or isolated psychotic symptoms.

Of those at high risk, 20 developed schizophrenia within 2.5 years. Just over half of those who fell ill were in the 'psychotic or possibly psychotic symptoms' group on entry to the study. However, many of the high-risk group who did not fall ill were just as symptomatic on entry as any of those who did.

The filmed records of interviews from this study show that such symptoms often appear to have been associated with little distress or functional impairment. They may be short-lived and followed by years in which they do not occur at all.

Those who developed schizophrenia differed from those who did not on social anxiety, withdrawal and other 'schizotypal' features, all of which were best assessed by simple behavioural and cognitive measures. Other measures, particularly in terms of neuropsychology, were also predictive, especially assessments of episodic memory (which are suggestive of temporal lobe dysfunction).

The authors of the study comment that the findings are consistent with the view that schizophrenia is primarily a disorder of temporal lobe structure and function that develops slowly over several years. The exact nature of the change that pushes an individual into psychosis is not yet clear, but continuing studies, particularly of functional brain imaging, may reveal this.

 

- Br J Psychiatry 2005 186 (1) Pages 18-25
 

 
Subscribe to Schizophrenia Newsletter
E-mail Address:

 

Predicting schizophrenia: findings from the Edinburgh High-Risk Study

E. C. Johnstone, K. P. Ebmeier, P. Miller, D. G. C. Owens and S. M.Lawrie


Related Schizophrenia News

Study aims to identify schizophrenics at risk for type 2 diabetes
Effects of ketamine mimic only some of the symptoms of schizophrenia
Association between famine and schizophrenia may yield clues about genetic basis
Neuropeptide S (NPS) may help in treating schizophrenia
Neuropeptide S (NPS) may help in treating schizophrenia
NMDA receptor hypofunction demonstrated in schizophrenia
Altered NRG1-erbB4 signaling may contribute to NMDA receptor hypofunction in schizophrenia
Transcription factor Elk-1's role in neurodegeneration and schizophrenia
Schizophrenia limits one's ability to perceive body language
Hospitalized schizophrenics are at a higher risk for developing medical/surgical complications


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us